Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

N Engl J Med. 2022 Feb 3;386(5):494-496. doi: 10.1056/NEJMc2119270. Epub 2021 Dec 29.

Authors

Shirley Collie¹, Jared Champion¹, Harry Moultrie², Linda-Gail Bekker³, Glenda Gray⁴

Affiliations

¹ Discovery Health, Johannesburg, South Africa.
² National Institute of Communicable Diseases, Johannesburg, South Africa.
³ Desmond Tutu HIV Foundation, Cape Town, South Africa.
⁴ South African Medical Research Council, Cape Town, South Africa glenda.gray@mrc.ac.za.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine*
Humans
Logistic Models
SARS-CoV-2*
South Africa
Vaccine Efficacy*

Substances

BNT162 Vaccine

Supplementary concepts

SARS-CoV-2 variants